SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-032005
Filing Date
2024-04-11
Accepted
2024-04-11 08:13:16
Documents
38
Period of Report
2024-04-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0203252-6k_enlivex.htm 6-K 17381
2 PRESS RELEASE ISSUED BY ENLIVEX THERAPEUTICS LTD. ON APRIL 11, 2024 ea020325202ex99-1_enlivex.htm EX-99.1 18955
3 INVESTOR PRESENTATION ea020325202ex99-2_enlivex.htm EX-99.2 52778
4 GRAPHIC ex99-1_001.jpg GRAPHIC 8352
5 GRAPHIC ex99-2_001.jpg GRAPHIC 167240
6 GRAPHIC ex99-2_002.jpg GRAPHIC 698714
7 GRAPHIC ex99-2_003.jpg GRAPHIC 482200
8 GRAPHIC ex99-2_004.jpg GRAPHIC 471107
9 GRAPHIC ex99-2_005.jpg GRAPHIC 548685
10 GRAPHIC ex99-2_006.jpg GRAPHIC 555920
11 GRAPHIC ex99-2_007.jpg GRAPHIC 508827
12 GRAPHIC ex99-2_008.jpg GRAPHIC 568628
13 GRAPHIC ex99-2_009.jpg GRAPHIC 301272
14 GRAPHIC ex99-2_010.jpg GRAPHIC 512141
15 GRAPHIC ex99-2_011.jpg GRAPHIC 133741
16 GRAPHIC ex99-2_012.jpg GRAPHIC 482469
17 GRAPHIC ex99-2_013.jpg GRAPHIC 435231
18 GRAPHIC ex99-2_014.jpg GRAPHIC 398198
19 GRAPHIC ex99-2_015.jpg GRAPHIC 332080
20 GRAPHIC ex99-2_016.jpg GRAPHIC 403390
21 GRAPHIC ex99-2_017.jpg GRAPHIC 403725
22 GRAPHIC ex99-2_018.jpg GRAPHIC 470432
23 GRAPHIC ex99-2_019.jpg GRAPHIC 474098
24 GRAPHIC ex99-2_020.jpg GRAPHIC 377864
25 GRAPHIC ex99-2_021.jpg GRAPHIC 636026
26 GRAPHIC ex99-2_022.jpg GRAPHIC 453652
27 GRAPHIC ex99-2_023.jpg GRAPHIC 680183
28 GRAPHIC ex99-2_024.jpg GRAPHIC 142098
29 GRAPHIC ex99-2_025.jpg GRAPHIC 394758
30 GRAPHIC ex99-2_026.jpg GRAPHIC 485791
31 GRAPHIC ex99-2_027.jpg GRAPHIC 389636
32 GRAPHIC ex99-2_028.jpg GRAPHIC 314043
33 GRAPHIC ex99-2_029.jpg GRAPHIC 426451
34 GRAPHIC ex99-2_030.jpg GRAPHIC 295067
35 GRAPHIC ex99-2_031.jpg GRAPHIC 256203
36 GRAPHIC ex99-2_032.jpg GRAPHIC 349846
37 GRAPHIC ex99-2_033.jpg GRAPHIC 393620
38 GRAPHIC ex99-2_034.jpg GRAPHIC 86534
  Complete submission text file 0001213900-24-032005.txt   19427574
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 24837175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)